2-Bromo-TMA

2-Bromo-TMA
Clinical data
Other names2-Br-TMA; 2-Bromo-3,4,5-trimethoxyamphetamine; BTMA
Routes of
administration		Oral[1]
Drug classSerotonergic psychedelic; Hallucinogen
ATC code
  • None
Pharmacokinetic data
Duration of action8 hours[1]
Identifiers
  • 1-(2-bromo-3,4,5-trimethoxyphenyl)propan-2-amine
Chemical and physical data
FormulaC12H18BrNO3
Molar mass304.184 g·mol−1
3D model (JSmol)
  • COc1cc(CC(N)C)c(c(c1OC)OC)Br
  • InChI=1S/C12H18BrNO3/c1-7(14)5-8-6-9(15-2)11(16-3)12(17-4)10(8)13/h6-7H,5,14H2,1-4H3
  • Key:XQNPOMXGYULEPE-UHFFFAOYSA-N

2-Bromo-TMA, or 2-Br-TMA, also known as 2-bromo-3,4,5-trimethoxyamphetamine, is a psychedelic drug of the phenethylamine, amphetamine, and 3C families related to 3,4,5-trimethoxyamphetamine (TMA).[1] It is the 2-brominated derivative of TMA.[1] The drug's dose is approximately 200 mg orally and its duration is approximately 8 hours.[1] Compared to TMA, 2-bromo-TMA is described as being only slightly less potent, being more active in altering visual perception, and having fewer physical side effects in comparison.[1] 2-Bromo-TMA was described in the scientific literature by Daniel Trachsel and colleagues in 2013, who cited personal communication with P. Rausch in 2009 for the information.[1]

See also

References

  1. ^ a b c d e f g Trachsel D, Lehmann D, Enzensperger C (2013). Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German) (1 ed.). Solothurn: Nachtschatten-Verlag. pp. 896, 907–908. ISBN 978-3-03788-700-4. OCLC 858805226.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.